« Back to Record
Van Damme, K. K., Hoste, L., Declercq, J., De Leeuw, E., Maes, B., Martens, L., Colman, R., Browaeys, R., Bosteels, C., Verwaerde, S., Vermeulen, N., Lameire, S., Debeuf, N., Deckers, J., Stordeur, P., Depuydt, P., Van Braeckel, E., Vandekerckhove, L., Guilliams, M., Schetters, S., Haerynck, F., Tavernier, S. S., & Lambrecht, B. (2023). A complement atlas identifies interleukin-6–dependent alternative pathway dysregulation as a key druggable feature of COVID-19. Science Translational Medicine, 15(710), eadi0252. doi:10.1126/scitranslmed.adi0252
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/370706



